Stem cells (Regenerative medicine)

OrgaNext pioneers treatment for the elderly

Interviewee/Contributer: Marjanne Prins

Organisation: OrgaNext Research BV

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Time to engage with stem-cell therapy

Interviewee/Contributer: Alain Vertès

Organisation: London Business School

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Making sense of the ECJ's decision on stem cell patents

Interviewee/Contributer: Nick Bassil

Organisation: Kilburn & Strode LLP

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Cardio3 BioSciences demonstrates how cardiac precurser cells treat heart disease

Interviewee/Contributer: Christian Homsy et al

Organisation: Cardiac3 BioSciences SA

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Shire Plc adds new dimension to its strategy

Interviewee/Contributer: Gwen Melincoff

Organisation: Shire Plc

Full text available to subscribers only. Click here for information on subscribing to MedNous.

How induced pluripotent stem cells are becoming a tool for personalised medicine

Interviewee/Contributer: Chris Parker

Organisation: Cellular Dynamics International

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Cellzome secures a lead in drug discovery

Interviewee/Contributer: Tim Edwards

Organisation: Cellzome

Full text available to subscribers only. Click here for information on subscribing to MedNous.

The future of embryonic stem cell research in the US

Interviewee/Contributer: Laura Smart

Organisation: Tiber Creek Partners LLC

Full text available to subscribers only. Click here for information on subscribing to MedNous.

When is the right time for Pharma to develop stem cell technology

Interviewee/Contributer: Alain Vertès

Organisation: London Business School

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Syndicate content